See the DrugPatentWatch profile for cosentyx

The safety of receiving vaccines while taking Cosentyx (secukinumab) is a crucial consideration for patients undergoing treatment for moderate to severe plaque psoriasis, psoriatic arthritis, or ankylosing spondylitis. Cosentyx is a biologic medication that targets interleukin-17A (IL-17A), a protein involved in the immune response.

According to the Cosentyx prescribing information [1], there is no specific recommendation for the administration of vaccines in patients taking Cosentyx. However, as with any immunosuppressive therapy, patients should be advised to avoid live vaccines while taking Cosentyx. Live vaccines, such as the MMR (measles, mumps, and rubella) vaccine, can pose a risk of infection to the patient and potentially spread the disease to others.

On the other hand, inactivated vaccines, such as the flu vaccine, are generally considered safe for patients taking immunosuppressive therapies like Cosentyx. Inactivated vaccines do not contain live viruses or bacteria, making them a suitable option for patients undergoing immunosuppressive therapy.

It is essential to note that patients taking Cosentyx should consult their healthcare provider before receiving any vaccine. Healthcare providers should consider the patient's individual risk factors, medical history, and the specific vaccine being administered when making a decision.

In conclusion, while there is no specific guidance on the administration of vaccines in patients taking Cosentyx, it is recommended to avoid live vaccines and consult with a healthcare provider before receiving any vaccine.

Sources:

[1] Novartis Pharmaceuticals Corporation. (2020). Cosentyx (secukinumab) injection, for subcutaneous use. Prescribing information.

[2] Centers for Disease Control and Prevention. (2020). Vaccines and immunizations. Retrieved from <https://www.cdc.gov/vaccines/index.html>

[3] DrugPatentWatch.com. (2020). Cosentyx (secukinumab) patents. Retrieved from <https://www.drugpatentwatch.com/patents/cosentyx-secukinumab/>

Note: The information provided is based on the available data and should not be considered as medical advice. Patients should consult their healthcare provider for personalized guidance.